Gut microbiota analysis in children with autism spectrum disorder and their family members.

Researchers studied the gut bacteria of autistic children, their siblings, and parents from the same families. They found that autistic children had different gut bacteria patterns - less of the 'good' bacteria called Bifidobacterium and more of other types called Bacteroides and Clostridium. These differences were linked to autism symptoms, suggesting gut health might play a role in autism.

This family-based study examined gut microbiota in 19 children with ASD, 8 non-ASD siblings, and 36 parents across 17 families. The unique design controlled for shared genetic and environmental factors that confound many microbiome studies. Metagenomic sequencing revealed significant differences in gut microbiota diversity and composition between groups. Children with ASD showed lower levels of Bifidobacterium and higher levels of Bacteroides and Clostridium species compared to their siblings.

These microbiota alterations correlated with ASD-specific symptoms, suggesting potential involvement in autism pathogenesis through the gut-brain axis.

Findings suggest gut microbiota may influence autism symptoms through the gut-brain axis. Results support potential for microbiome-targeted interventions, though larger studies are needed. The family-based design strengthens confidence in autism-specific microbiota differences by controlling for genetic and environmental confounds.

Small sample size (19 ASD children) limits generalizability. Cross-sectional design cannot establish causation. Study type and specific methodology details not clearly reported in abstract. Correlation between microbiota and symptoms requires validation.

Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by deficits in social communication and interaction, alongside restricted, and repetitive behaviors. Emerging evidence suggests that gut microbiota alterations may contribute to ASD pathogenesis via the gut-brain axis. However, many previous studies have not adequately controlled for confounding genetic and environmental variables. In this study, we examined the gut microbiota profiles of 19 children with ASD, 8 siblings with non-ASD, and 36 parents from 17 families, providing a unique design that minimized biases related to shared genetic and familial environments.

Metagenomic sequencing revealed significant differences in gut microbiota diversity and composition between groups. Specifically, children with ASD had lower abundances of Bifidobacterium and higher abundances of both Bacteroides and Clostridium species compared to their siblings, with notable dysbiosis correlated to ASD-specific symptoms. These findings highlight the potential role of microbiota alterations in ASD pathogenesis and suggest familial microbiota traits influenced by both genetic and environmental factors. Further exploration of gut microbial therapies could offer promising avenues for ASD intervention.